Fortis Healthcare was up 3.13% to Rs 163.30 at 12:46 IST on BSE after the Reserve Bank of India on Friday, 7 July 2017, approved hiking foreign investment ceiling in the company upto 74% of the paid-up equity capital.
Meanwhile, the S&P BSE Sensex was up 222.25 points or 0.71% at 31,582.88. The S&P BSE Mid-Cap index rose 58.28 points or 0.39% at 15,000.05.
On the BSE, 4.56 lakh shares were traded on the counter so far as against the average daily volumes of 9.83 lakh shares in the past one quarter. The stock had hit a high of Rs 163.90 and a low of Rs 162 so far during the day. The stock had hit a record high of Rs 230.90 on 3 May 2017 and a 52-week low of Rs 142.60 on 9 November 2016.
The stock had underperformed the market over the past one month till 7 July 2017, sliding 18.4% compared with the Sensex's 0.29% rise. The stock had also underperformed the market over the past one quarter, declining 14.87% as against the Sensex's 5.57% rise. The scrip had also underperformed the market over the past one year, declining 0.57% as against the Sensex's 15.29% rise.
The mid-cap company has equity capital of Rs 518.52 crore. Face value per share is Rs 10.
Fortis Healthcare reported consolidated net loss of Rs 37.52 crore in Q4 March 2017 compared with net loss of Rs 87.60 crore in Q4 March 2016. Net sales rose 5% to Rs 1123.43 crore in Q4 March 2017 over Q4 March 2016.
Fortis Healthcare is a leading integrated healthcare delivery service provider in India.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content